Bruker Corporation (BRKR)
Stock Price Chart
Key Info
| Market Cap | 6.73B |
| Revenue (ttm) | 1.97B |
| Net Income (ttm) | 164.50M |
| Shares Out | 153.08M |
| EPS (ttm) | 1.05 |
| PE Ratio | 41.90 |
| Forward PE | 39.53 |
| Dividend | $0.16 |
| Dividend Yield | 0.36% |
Stock Quote
| Trading Day | Aug 13, 2020 |
| Last Price | $43.99 |
| Previous Close | $43.97 |
| Change ($) | 0.02 |
| Change (%) | 0.05% |
| Day's Open | 43.89 |
| Day's Range | 43.46 - 44.17 |
| Day's Volume | 222,167 |
| 52-Week Range | 30.78 - 54.49 |
More Stats
| Market Cap | 6.73B |
| Enterprise Value | 7.00B |
| Earnings Date (est) | Oct 29, 2020 |
| Ex-Dividend Date | May 29, 2020 |
| Shares Outstanding | 153.08M |
| Float | 102.11M |
| EPS (basic) | 1.07 |
| EPS (diluted) | 1.05 |
| FCF / Share | 0.98 |
| Dividend | $0.16 |
| Dividend Yield | 0.36% |
| Earnings Yield | 2.39% |
| FCF Yield | 2.24% |
| Payout Ratio | n/a |
| Shares Short | 2.92M |
| Short Ratio | 4.65 |
| Short % of Float | 3.77% |
| Beta | 1.38 |
| PE Ratio | 41.90 |
| Forward PE | 39.53 |
| P/FCF Ratio | 44.60 |
| PS Ratio | 3.42 |
| PB Ratio | 7.44 |
| Revenue | 1.97B |
| Operating Income | 259.80M |
| Net Income | 164.50M |
| Free Cash Flow | 151.00M |
| Net Cash | -270.50M |
| Net Cash / Share | -1.77 |
| Gross Margin | 50.80% |
| Operating Margin | 13.19% |
| Profit Margin | 8.40% |
| FCF Margin | 7.67% |
| ROA | 6.03% |
| ROE | 18.36% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,073 | 1,896 | 1,766 | 1,611 | 1,624 | 1,809 | 1,839 | 1,791 | 1,652 | 1,305 |
| Revenue Growth | 9.34% | 7.34% | 9.59% | -0.77% | -10.23% | -1.66% | 2.68% | 8.46% | 26.58% | - |
| Gross Profit | 995 | 900 | 816 | 745 | 709 | 763 | 805 | 829 | 753 | 604 |
| Operating Income | 301 | 262 | 220 | 182 | 146 | 105 | 148 | 156 | 159 | 156 |
| Net Income | 197 | 180 | 78.60 | 154 | 102 | 56.70 | 80.10 | 77.50 | 92.30 | 95.40 |
| Shares Outstanding | 155 | 156 | 158 | 161 | 168 | 168 | 167 | 166 | 165 | 164 |
| Earnings Per Share | 1.26 | 1.14 | 0.49 | 0.95 | 0.60 | 0.33 | 0.48 | 0.46 | 0.55 | 0.58 |
| EPS Growth | 10.53% | 132.65% | -48.42% | 58.33% | 81.82% | -31.25% | 4.35% | -16.36% | -5.17% | - |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | - | - | - | - | - | - |
| Dividend Growth | 0% | 0% | 0% | - | - | - | - | - | - | - |
| Operating Cash Flow | 213 | 240 | 154 | 131 | 229 | 114 | 145 | 133 | 87.70 | 156 |
| Capital Expenditures | -62.00 | -48.80 | -32.20 | -36.00 | -33.30 | -30.70 | -48.90 | -69.50 | -54.40 | -29.20 |
| Free Cash Flow | 151 | 191 | 122 | 94.80 | 196 | 83.60 | 96.10 | 63.60 | 33.30 | 127 |
| Cash & Equivalents | 685 | 322 | 439 | 500 | 468 | 498 | 439 | 311 | 246 | 233 |
| Total Debt | 860 | 341 | 416 | 412 | 266 | 355 | 355 | 337 | 303 | 301 |
| Net Cash / Debt | -175 | -18.70 | 23.60 | 88.60 | 203 | 143 | 83.70 | -26.60 | -57.10 | -67.70 |
| Assets | 2,772 | 2,129 | 1,949 | 1,808 | 1,730 | 1,865 | 1,988 | 1,856 | 1,711 | 1,550 |
| Liabilities | 1,854 | 1,224 | 1,215 | 1,115 | 997 | 1,093 | 1,138 | 1,147 | 1,086 | 1,022 |
| Book Value | 907 | 897 | 725 | 686 | 726 | 766 | 846 | 707 | 622 | 525 |
Company Profile
Company Details
| Full Name | Bruker Corporation |
| Country | United States |
| Employees | 7,000 |
| CEO | Frank H. Laukien |
Stock Information
| Ticker Symbol | BRKR |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Unique Identifier | NASDAQ: BRKR |
| IPO Date | August 4, 2000 |
Description
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation has collaboration with Inscopix. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.